These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 33836300

  • 1. Investigation of the arcane inhibition of human organic anion transporter 3 by benzofuran antiarrhythmic agents.
    Tan HL, Tang LWT, Chin SY, Chan ECY.
    Drug Metab Pharmacokinet; 2021 Jun; 38():100390. PubMed ID: 33836300
    [Abstract] [Full Text] [Related]

  • 2. Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites.
    Karkhanis A, Lam HY, Venkatesan G, Koh SK, Chai CL, Zhou L, Hong Y, Kojodjojo P, Chan EC.
    Biochem Pharmacol; 2016 May 01; 107():67-80. PubMed ID: 26972388
    [Abstract] [Full Text] [Related]

  • 3. Application of Static Modeling --in the Prediction of In Vivo Drug-Drug Interactions between Rivaroxaban and Antiarrhythmic Agents Based on In Vitro Inhibition Studies.
    Cheong EJ, Goh JJ, Hong Y, Venkatesan G, Liu Y, Chiu GN, Kojodjojo P, Chan EC.
    Drug Metab Dispos; 2017 Mar 01; 45(3):260-268. PubMed ID: 28053220
    [Abstract] [Full Text] [Related]

  • 4. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
    Karkhanis A, Tram NDT, Chan ECY.
    Biochem Pharmacol; 2017 Dec 15; 146():188-198. PubMed ID: 28958841
    [Abstract] [Full Text] [Related]

  • 5. Development and verification of a physiologically based pharmacokinetic model of dronedarone and its active metabolite N-desbutyldronedarone: Application to prospective simulation of complex drug-drug interaction with rivaroxaban.
    Leow JWH, Ang XJ, Chan ECY.
    Br J Clin Pharmacol; 2023 Jun 15; 89(6):1873-1890. PubMed ID: 36683488
    [Abstract] [Full Text] [Related]

  • 6. Systematic Development and Verification of a Physiologically Based Pharmacokinetic Model of Rivaroxaban.
    Cheong EJY, Teo DWX, Chua DXY, Chan ECY.
    Drug Metab Dispos; 2019 Nov 15; 47(11):1291-1306. PubMed ID: 31506301
    [Abstract] [Full Text] [Related]

  • 7. Febuxostat and its major acyl glucuronide metabolite are potent inhibitors of organic anion transporter 3: Implications for drug-drug interactions with rivaroxaban.
    Tang LWT, Cheong TWH, Chan ECY.
    Biopharm Drug Dispos; 2022 Apr 15; 43(2):57-65. PubMed ID: 35088420
    [Abstract] [Full Text] [Related]

  • 8. Predicting drug-drug interactions with physiologically based pharmacokinetic/pharmacodynamic modelling and optimal dosing of apixaban and rivaroxaban with dronedarone co-administration.
    Wen HN, He QF, Xiang XQ, Jiao Z, Yu JG.
    Thromb Res; 2022 Oct 15; 218():24-34. PubMed ID: 35985100
    [Abstract] [Full Text] [Related]

  • 9. Clinical pharmacology of dronedarone: implications for the therapy of atrial fibrillation.
    Dorian P.
    J Cardiovasc Pharmacol Ther; 2010 Dec 15; 15(4 Suppl):15S-8S. PubMed ID: 20472816
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of the rivaroxaban-dronedarone interaction: insights from physiologically based pharmacokinetic modelling.
    Hügl B, Horlitz M, Fischer K, Kreutz R.
    Eur Heart J Open; 2023 Jan 15; 3(1):oead004. PubMed ID: 36820238
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory Effects of Dronedarone on Small Conductance Calcium Activated Potassium Channels in Patients with Chronic Atrial Fibrillation: Comparison to Amiodarone.
    Yu Y, Luo D, Li Z, Zhang J, Li F, Qiao J, Yu F, Li M.
    Med Sci Monit; 2020 May 29; 26():e924215. PubMed ID: 32470968
    [Abstract] [Full Text] [Related]

  • 12. Effect of antiarrhythmic drugs on small conductance calcium - activated potassium channels.
    Simó-Vicens R, Sauter DRP, Grunnet M, Diness JG, Bentzen BH.
    Eur J Pharmacol; 2017 May 15; 803():118-123. PubMed ID: 28322838
    [Abstract] [Full Text] [Related]

  • 13. Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.
    Chiou WR, Huang CC, Lin PL, Chuang JY, Liu LY, Su MI, Liao FC, Chen CY, Kuo JY, Tsai CT, Wu YJ, Lee YH.
    Am J Cardiovasc Drugs; 2021 Jul 15; 21(4):459-469. PubMed ID: 33369716
    [Abstract] [Full Text] [Related]

  • 14. Interaction of human organic anion transporter 2 (OAT2) and sodium taurocholate cotransporting polypeptide (NTCP) with antineoplastic drugs.
    Marada VV, Flörl S, Kühne A, Müller J, Burckhardt G, Hagos Y.
    Pharmacol Res; 2015 Jan 15; 91():78-87. PubMed ID: 25481222
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of potential herb-drug interactions between oseltamivir and commonly used anti-influenza Chinese medicinal herbs.
    Zhang Y, Lyu C, Fong SYK, Wang Q, Li C, Ho NJ, Chan KS, Yan X, Zuo Z.
    J Ethnopharmacol; 2019 Oct 28; 243():112097. PubMed ID: 31325600
    [Abstract] [Full Text] [Related]

  • 16. Comparison of co-administration of amiodarone and rivaroxaban to co-administration of dronedarone and rivaroxaban for hemorrhage risks after atrial fibrillation ablation.
    Zhang P, Wang M, Liu W, Sun P, Cai S, Pan Y, Zhao Q.
    J Interv Card Electrophysiol; 2022 Jun 28; 64(1):121-127. PubMed ID: 35050451
    [Abstract] [Full Text] [Related]

  • 17. Dronedarone for atrial fibrillation therapy.
    Marzocchi M, Lombardi F.
    Expert Rev Cardiovasc Ther; 2011 Jun 28; 9(6):675-83. PubMed ID: 21714598
    [Abstract] [Full Text] [Related]

  • 18. Dronedarone--a new alternative for management of atrial fibrillation.
    Hundal M, Garg RK.
    Recent Pat Cardiovasc Drug Discov; 2010 Jan 28; 5(1):47-53. PubMed ID: 20001929
    [Abstract] [Full Text] [Related]

  • 19. Dronedarone: a review of characteristics and clinical data.
    Baroletti S, Catella J, Ehle M, Cheng JW.
    Crit Pathw Cardiol; 2010 Jun 28; 9(2):94-101. PubMed ID: 20520217
    [Abstract] [Full Text] [Related]

  • 20. Dronedarone for the management of atrial fibrillation.
    Brenner R, Delacrétaz E.
    Swiss Med Wkly; 2011 Jun 28; 141():w13158. PubMed ID: 21370206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.